The NIH-Duke Master's Program in Clinical Research, established in 1998, is one of the nation's first training programs in clinical research. This program allows participants to attend formal courses in research design, research management, medical genomics, and statistical analysis at the Clinical Center by means of video-conferencing from Duke or on-site by adjunct faculty.
The program leads to a Master of Health Sciences in Clinical Research, a professional degree awarded by the Duke University School of Medicine. There is also a non-degree option for qualified students who want to pursue specific areas of interest.
Applications will be accepted through August 1, 2020.
The objective of this course is to provide a thorough grounding in the conduct of randomized clinical trials to researchers and health professionals interested in developing competence in the planning, design, and execution of randomized clinical trials involving behavioral interventions.
The curriculum will enable participants to:
- Describe the principles underlying the conduct of unbiased clinical trials
- Identify the unique challenges posed by behavioral randomized clinical trials (RCTs)
- Evaluate RCT designs in terms of their appropriateness to scientific and clinical goals
- Select appropriate strategies for enrollment, randomization, and retention of participants
- Understand methods for monitoring, coordinating, and conducting RCTs
- Develop strategies for appropriate statistical analyses of RCT data
- Evaluate the quality of behavioral RCTs and interpret their results
- Design an RCT as part of a working group on a specific topic.